Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 3;17(10):3729-3734.
doi: 10.1080/21645515.2021.1928461. Epub 2021 Jun 7.

Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China

Affiliations

Analysis of epidemiological serosurvey of hepatitis B virus among people under 29 years of age in Jiangsu Province, China

Xiang Sun et al. Hum Vaccin Immunother. .

Abstract

Background: The purpose of this paper was to analyze the prevalence of hepatitis B surface antigen (HBsAg), hepatitis B surface antibody (anti-HBs), and hepatitis B core anti-body (anti-HBc)in1-29 years old living in the most populous eastern province of China,22 years after introduction of hepatitis B vaccine (HepB) vaccination of infants and provide provincial baseline data for developping a better prevention and control plan for hepatitis B virus (HBV)in Jiangsu Province, ChinaMethods: The incidence rates of HBV in Jiangsu province from 2004 to 2014 were obtained from the National Notifiable Disease Reporting System (NNDRS). A stratified cluster random sampling method was used to select 3,002 participants aged 1-29 years across 13 HBV monitoring points throughout the province, which had been classified as either urban or rural. HBV serological markers were measured by Abbott microparticle enzyme immunoassay (MEIA) kits (Abbott Laboratories, Chicago, Illinois).Results: The incidence of hepatitis B decreased by approximately 71.44% in Jiangsu province between 2004 and 2014. Serological assessments showed that the prevalence of the HBsAg, anti-HBc, and anti-HBsin the 1-29 age group were 1.20%, 5.33%,and 66.89%, respectively. There was a significantly lower prevalence of HepB who were vaccinated than in unvaccinated subjects (0.46% vs 14.93%, p < .0001). Among these the ages of 1-29, the coverage rate drops from 97.7% to 56.6% with age,andthe timely rate among people aged 1-14 years was 90.93%.Conclusions: Since the HepB was integrated into the immunization programme in Jiangsu province,the rate of hepatitis B reported and the prevalence of HBsAg decreased significantly, and the coverage of HepB and the vaccination rate within 24 hours after birth have played an important role in reducing HBV infection.

Keywords: Hepatitis B; immunization; serosurvey.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Seroprevalence of HBV markers among participants by age group
Figure 2.
Figure 2.
The incidence rates of HBV in Jiangsu province between 2004 and 2014

Similar articles

Cited by

References

    1. Kulik L, El-Serag HB.. Epidemiology and management of hepatocellular carcinoma. Gastroenterology. 2019;156(2):477–91 e1. doi:10.1053/j.gastro.2018.08.065. - DOI - PMC - PubMed
    1. Zhou KN, Zhang M, Wu Q, Ji ZH, Zhang XM, Zhuang GH.. Psychometrics of chronic liver disease questionnaire in Chinese chronic hepatitis B patients. World J Gastroenterol. 2013;19:3494–501. doi:10.3748/wjg.v19.i22.3494. - DOI - PMC - PubMed
    1. Liao X, Liang Z. Strategy vaccination against Hepatitis B in China. Hum Vaccin Immunother. 2015;11:1534–39. - PMC - PubMed
    1. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Reprint of: epidemiological serosurvey of Hepatitis B in China–declining HBV prevalence due to Hepatitis B vaccination. Vaccine. 2013;31(Suppl 9):J21–8. doi:10.1016/j.vaccine.2013.08.012. - DOI - PubMed
    1. Wang FZ, Cui FQ. The immunoprophylaxis strategy of prevention mother to child transmission of hepatitis B virus (in Chinese). Chin J Vaccines Immunization. 2014;20:355–59.

Publication types

Substances

Grants and funding

This work was supported by Chinese Foundation For Hepatitis Prevention and Control under grant number [YGFK20190027].